- Home
- EDN vs CNMD Comparison
EDN vs CNMD Comparison
Compare EDN & CNMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EDN
- CNMD
- Stock Information
- Founded
- EDN 1992
- CNMD 1970
- Country
- EDN Argentina
- CNMD United States
- Employees
- EDN N/A
- CNMD N/A
- Industry
- EDN Electric Utilities: Central
- CNMD Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- EDN Utilities
- CNMD Health Care
- Exchange
- EDN Nasdaq
- CNMD Nasdaq
- Market Cap
- EDN 1.5B
- CNMD 1.7B
- IPO Year
- EDN 2007
- CNMD 1987
- Fundamental
- Price
- EDN $32.31
- CNMD $57.08
- Analyst Decision
- EDN
- CNMD Buy
- Analyst Count
- EDN 0
- CNMD 5
- Target Price
- EDN N/A
- CNMD $62.20
- AVG Volume (30 Days)
- EDN 129.6K
- CNMD 557.6K
- Earning Date
- EDN 03-11-2025
- CNMD 04-30-2025
- Dividend Yield
- EDN N/A
- CNMD 1.39%
- EPS Growth
- EDN 42.19
- CNMD 46.38
- EPS
- EDN 0.30
- CNMD 3.81
- Revenue
- EDN $1,981,694,257.00
- CNMD $1,315,998,000.00
- Revenue This Year
- EDN $51.74
- CNMD $5.97
- Revenue Next Year
- EDN N/A
- CNMD $5.63
- P/E Ratio
- EDN $5.10
- CNMD $15.14
- Revenue Growth
- EDN 33.82
- CNMD 4.32
- 52 Week Low
- EDN $13.78
- CNMD $46.00
- 52 Week High
- EDN $51.69
- CNMD $78.58
- Technical
- Relative Strength Index (RSI)
- EDN 54.60
- CNMD 56.51
- Support Level
- EDN $29.34
- CNMD $54.83
- Resistance Level
- EDN $30.77
- CNMD $58.58
- Average True Range (ATR)
- EDN 1.69
- CNMD 2.04
- MACD
- EDN 0.10
- CNMD 1.07
- Stochastic Oscillator
- EDN 65.47
- CNMD 77.14
About EDN Empresa Distribuidora Y Comercializadora Norte S.A. (Edenor)
Empresa Distribuidora y Comercializadora Norte SA is engaged in the distribution and sale of electricity. The firm's concession area covers the northern portion of the city of Buenos Aires mainly to residential, commercial, industrial, and public service.
About CNMD CONMED Corporation
Conmed Corp is a Utica, New York-based medical equipment company that focuses on sports medicine procedures and general surgeries. The firm currently reports through two reporting units, orthopedic surgery, and general surgery. From a geographic perspective, the firm is U.S.-centric, with maximum domestic sales accounting for revenue, EMEA accounting for second place, APAC at third, and the non-U.S. Americas region driving the remaining revenue.